INS and type 2 diabetes mellitus: As one of the hallmarks of insulin resistance is impaired glycogen synthesis in skeletal muscle during in vivo insulin stimulation [17, 18, 35], our observation that roxadustat treatment enhanced insulin action on glycogen synthesis in myotubes from donors with type 2 diabetes is exciting.